# Structural basis for transport and inhibition of nucleotide sugar transport in pathogenic fungi

## TL;DR

This paper reveals the structure of a key transporter in pathogenic fungi and shows how it can be inhibited, offering a new approach for antifungal treatments.

## Contribution

The study provides cryo-EM structures of a GDP-mannose transporter and demonstrates nanobody inhibition of fungal glycosylation.

## Key findings

- Cryo-EM structures of Vrg4 in cytoplasmic and Golgi-facing states reveal transport mechanism.
- Nanobodies specifically inhibit Vrg4, blocking nucleotide sugar transport in cells.
- Ligand movement is essential for transporter function as shown by structural comparisons.

## Abstract

GDP-Mannose transporters are Golgi-localised solute carriers that are essential for the virulence of pathogenic fungi, serving as critical components of fungal glycosylation pathways. However, the mechanism by which nucleotide sugars are recognised and transported across the Golgi membrane remains unclear, hindering efforts to develop effective inhibitors that could serve as novel antifungal agents. Here, we present cryo-EM structures of the GDP-Mannose transporter, Vrg4, from Candida albicans in complex with nanobodies and in both the cytoplasmic and Golgi-facing states. Structural comparisons between these two states, in addition to a GDP-mannose bound structure, demonstrate the importance of ligand movement during transport. Additionally, we demonstrate the ability of the nanobodies to specifically inhibit Vrg4, presenting proof-of-principle that nanobodies can be used as effective inhibitors of nucleotide sugar transport and glycosylation in cells.